代写论文：选择性拮抗剂
选择性拮抗剂优于非选择性拮抗剂。这是因为他们对大脑的影响最小。另一方面，由于非选择性拮抗剂在脑中的影响更有害。选择性拮抗剂相对于非诺雌激素选择性拮抗剂的另一个主要优点是在非选择性拮抗剂的情况下缺乏与孕酮和雄激素的适当结合。这会导致药物诱发男性乳房发育，疼痛乳房和阳痿相关的问题。另一个优点是选择性拮抗剂不会导致血红蛋白水平的增加（Donnelly-Roberts等571-79）。因此，选择性拮抗剂可以给糖尿病患者。因此，可以清楚地说，选择性拮抗剂比非选择性有利得多。在非选择性拮抗剂的情况下，血浆脂联素水平降低。除此之外，HbA1C水平和对照水平也有增长。但是，这些是在非选择性拮抗剂的情况下很少观察到的事情。
代写论文：选择性拮抗剂
Selective antagonists are advantageous over non-selective antagonists. This is because they have the minimum impact on the brain. On the other hand, the impact due to the non-selective antagonists in the brain is more harmful. Another major advantage of the selective antagonist over the nopironolactonen –selective antagonist is that in case of the non-selective antagonist is the lack of proper binding with the progesterone and androgen. This can cause the problems such as the drug inducted gynecomastia, pain the breast and the problem related to impotence. Another advantage is that the selective antagonist does not lead to the increase in the levels of hemoglobin (Donnelly‐Roberts et al 571-79). Therefore, selective antagonist can be given to the people who are suffering from diabetes. Therefore, it can be clearly said that the selective antagonists is much better in comparison to the non-selective advantageous. In case of non- elective antagonist, there is the decrease in the levels of plasma adiponectin levels. Other than this there is also a growth in HbA1C levels and control levels as well. Though, these are the things that are rarely observed in case of the non-selective antagonists.